Aseptuva
Bern, Switzerland
◆ Total Raised
$2.9M
◆ Stage
seed
◆ Location
Bern, Switzerland
◆ Founded
2021
◆ Team size
1-10
◆ Links
◆ About Aseptuva
Swiss-UK medtech startup developing targeted Far-UVC disinfection technology to prevent hospital-acquired infections linked to intravenous catheters.
◆ What sets it apart
Uses guided Far-UVC technology in a catheter adaptor to deliver automated, hands-free disinfection at the point where infections originate.
◆ Sectors
◆ Business
Modelhardware
CustomerHospitals and healthcare providers
◆ Notable
- Raised CHF 2.9m seed funding
- Won a grant from NIHR Invention for Innovation
- Recognized as a Swiss-UK medtech startup tackling hospital-acquired infections
- Listed as based in Bern, Switzerland, with activity in the UK
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Aseptuva do?
Swiss-UK medtech startup developing targeted Far-UVC disinfection technology to prevent hospital-acquired infections linked to intravenous catheters.
Where is Aseptuva based?
Aseptuva is based in Bern, Switzerland, founded in 2021.
How much has Aseptuva raised?
Aseptuva has raised $2.9M in tracked funding and is currently at the seed stage.
Who has invested in Aseptuva?
Investors in Aseptuva include Simon Michel, Roger Nitsch, Armin Diethelm, Auxinam and weInvest.